ATUX ISKAY GROUP LLC
Atux Iskay Group, LLc
PLAINSBORO, United States · Founded 2020 · $1.7M raised
- Headquarters
- PLAINSBORO, New Jersey
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- atuxiskay.com
- Total Funding
- $1.7M
- Last Round
- $1.7M GrantJun 2023
- Rounds
- 2
About
Atux Iskay Group LLC is a Plainsboro, New Jersey biotech company developing small molecule modulators of the tumor suppressor Protein Phosphatase 2A (PP2A). The company focuses on oncology, neurodegenerative disease, and respiratory disease, leveraging senotherapeutic approaches to normalize PP2A function. Atux Iskay has received SBIR funding from the NIH and NJEDA.
Summary
ATUX ISKAY GROUP LLC is a Biotech company based in PLAINSBORO, United States, founded in 2020. It has raised $1.7M in total across 2 rounds, most recently a $1.7M Grant round in Jun 2023. Investors include Department of Health and Human Services.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2023
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.